Vitamin B6 modulates CD8+ T cell antitumor responses
Developmental Cell · 2026-03 · 61 (3) · 468-469
DOI: 10.1016/j.devcel.2026.02.015 ↗At a glance
Kommentar in Developmental Cell, 2026-03. Written by Iosifina P Foskolou. Institution: Sanquin Blood Supply Foundation, Department of Research, 1066 CX Amsterdam, the Netherlands; Landsteiner Laboratory, Amsterdam UMC, University of Ams…. Major MEDLINE topics: CD8-Positive T-Lymphocytes, Vitamin B 6, Neoplasms, Pyridoxal Phosphate. 10 references.
Abstract (original language)
In this issue of Developmental Cell, Wu et al. report that the active form of vitamin B6, pyridoxal phosphate (PLP), enhances CD8+ T cell-dependent tumor clearance. Mechanistically, PLP maintains CD8+ T cells in a stemness-like state by inhibiting the nuclear translocation of BACH2. Here, we discuss these findings and their implications for cancer immunotherapy.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Sanquin Blood Supply Foundation, Department of Research, 1066 CX Amsterdam, the Netherlands; Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, the Netherlands. Electronic address: i.fosk…
Cite
APA
Foskolou, I. P. (2026). Vitamin B6 modulates CD8+ T cell antitumor responses. Developmental Cell, 61(3), 468-469. https://doi.org/10.1016/j.devcel.2026.02.015
Vancouver
Foskolou IP. Vitamin B6 modulates CD8+ T cell antitumor responses. Developmental Cell. 2026;61(3):468-469. doi:10.1016/j.devcel.2026.02.015
BibTeX
@article{Foskolou2026,
author = {Foskolou, Iosifina P},
title = {Vitamin B6 modulates CD8+ T cell antitumor responses},
journal = {Developmental Cell},
year = {2026},
volume = {61},
number = {3},
pages = {468--469},
doi = {10.1016/j.devcel.2026.02.015}
}
EUVIMED